Jove R - Search Results

1

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Song L, Turkson J, Karras JG, Jove R, Haura EB. Song L, et al. Among authors: jove r. Oncogene. 2003 Jul 3;22(27):4150-65. doi: 10.1038/sj.onc.1206479. Oncogene. 2003. PMID: 12833138

2

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Niu G, et al. Among authors: jove r. Oncogene. 2002 Mar 27;21(13):2000-8. doi: 10.1038/sj.onc.1205260. Oncogene. 2002. PMID: 11960372

3

STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.

Velichko S, Wagner TC, Turkson J, Jove R, Croze E. Velichko S, et al. Among authors: jove r. J Biol Chem. 2002 Sep 20;277(38):35635-41. doi: 10.1074/jbc.M204578200. Epub 2002 Jun 24. J Biol Chem. 2002. PMID: 12105218 Free article.

4

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Among authors: jove r. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

5

Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.

Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P, Craig A, Elliott B, Raptis L. Vultur A, et al. Among authors: jove r. Oncogene. 2004 Apr 8;23(15):2600-16. doi: 10.1038/sj.onc.1207378. Oncogene. 2004. PMID: 15007380

6

Stat3 regulates genes common to both wound healing and cancer.

Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. Dauer DJ, et al. Among authors: jove r. Oncogene. 2005 May 12;24(21):3397-408. doi: 10.1038/sj.onc.1208469. Oncogene. 2005. PMID: 15735721

7

Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.

Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R. Nam S, et al. Among authors: jove r. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5998-6003. doi: 10.1073/pnas.0409467102. Epub 2005 Apr 18. Proc Natl Acad Sci U S A. 2005. PMID: 15837920 Free PMC article.

8

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.

Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H. Xu Q, et al. Among authors: jove r. Oncogene. 2005 Aug 25;24(36):5552-60. doi: 10.1038/sj.onc.1208719. Oncogene. 2005. PMID: 16007214

9

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.

Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB. Song L, et al. Among authors: jove r. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620. Cancer Res. 2006. PMID: 16740687

10

STATs in oncogenesis.

Bowman T, Garcia R, Turkson J, Jove R. Bowman T, et al. Among authors: jove r. Oncogene. 2000 May 15;19(21):2474-88. doi: 10.1038/sj.onc.1203527. Oncogene. 2000. PMID: 10851046 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page